DOCN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DigitalOcean is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to deploy. The stock has strong momentum, positive analyst revisions, and clear AI-driven growth catalysts. With no AI Stock Picker or SwingMax signal today, this is not a special signal-driven entry, but the broader setup still supports buying now rather than waiting. The main reason to buy is the combination of accelerating revenue growth, raised guidance, and bullish analyst target changes. I would classify DOCN as a buy for a patient long-term investor, but it is more attractive as a growth allocation than a core defensive holding.
DOCN shows a bullish technical structure. The MACD histogram is positive at 3.982, though slightly contracting, which suggests momentum remains favorable but may be cooling after the recent surge. The moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200, confirming an uptrend. RSI_6 at 71.133 is elevated, indicating the stock has already run up sharply and is near stretched levels, but not enough to negate the trend. Price at 158.895 is above the pivot of 137.01 and just under R1 at 162.256, so the stock is trading near a nearby breakout area. Near-term pattern analysis suggests a small pullback possible tomorrow, but positive follow-through over the next week and month remains likely.
Recent news is strongly positive: shares surged after DigitalOcean reported a 221% YoY increase in AI customer revenue and announced plans for significant data center expansion with an upgraded revenue growth forecast. Q1 revenue grew 22% YoY to $258 million, and the company raised FY26 revenue growth guidance to 25%-27%. Analysts are increasingly positive on DigitalOcean’s AI inference and capacity expansion story, with several firms lifting targets sharply. The company appears well positioned to benefit from accelerating AI workload adoption and better monetization of its platform.
The biggest negatives are insider selling, which has increased sharply over the last month, and the fact that the stock has already rallied hard, leaving RSI elevated. Some analysts still remain Neutral, signaling valuation and execution concerns. Growth is coming with margin and free cash flow pressure due to heavy AI infrastructure spending, and there is some concern that additional capital may eventually be needed if expansion continues aggressively. The technical setup is strong, but the stock is extended compared with its recent move.
The latest reported quarter is Q1. Financials were solid: revenue rose 22% year over year to $258 million, and management raised FY26 revenue growth guidance to 25%-27%. AI customer revenue grew 221% year over year, which is the clearest sign of accelerating demand. Non-GAAP net income fell 21% because of increased AI infrastructure spending, so profitability is under pressure in the near term, but the growth trend is improving materially.
Analyst sentiment has turned notably more constructive over the past week. UBS, Citi, Goldman Sachs, BofA, Morgan Stanley, Piper Sandler, Oppenheimer, Canaccord, and Barclays all raised price targets, with several firms keeping Buy/Overweight/Outperform ratings. Targets now range roughly from $155 to $200, versus the current price around $158.9, which implies moderate to meaningful upside depending on the model. The pros view is that DOCN is benefiting from AI-driven demand, capacity expansion, and stronger monetization. The cons view is that the story is execution-dependent, margins and free cash flow may stay pressured, and some firms remain Neutral due to these concerns. Overall, Wall Street is leaning bullish.
